AMD · AMD · 30 Dec 2017 TO 28 Dec 2019
Annual shareholder value expanded again as Ryzen, EPYC and 7nm products progressed.
Retrospective case study. These were not calls made by this platform. Source checking is not strategy validation.
The change being investigated
Retrospective interpretation. Contemporary sentiment evidence is incomplete. These descriptions are reconstructed research hypotheses, not measured market consensus.
THE SHAREHOLDER EXPERIENCE
Annual endpoints, with straight joins between observations. This context may extend beyond the selected episode.
The shaded area marks the selected episode within the full disclosed history. Annual endpoints cannot identify precise entry prices, exit prices or maximum drawdowns. A broad market or industry benchmark is context, not a risk-matched control.
| Observation date | AMD | S&P 500 total return |
|---|---|---|
| 27 Dec 2014 | 100 | 100 |
| 26 Dec 2015 | 110.19 | 100.77 |
| 31 Dec 2016 | 427.92 | 111.92 |
| 30 Dec 2017 | 387.92 | 136.35 |
| 29 Dec 2018 | 672.45 | 129.26 |
| 28 Dec 2019 | 1,742.64 | 171.64 |
Basis: Issuer-reported cumulative total return, $100 baseline at 27 December 2014. Fiscal-year endpoints only; no daily path or precise turning points.
AMD fiscal 2019 Form 10-K, Performance Graph ↗Published 4 Feb 2020. Later disclosures are outcome evidence, not earlier signals.
THE DATED EVIDENCE
Publication time determines when a source can support a historical signal. Reporting periods and later explanations stay separate.
issuer release · business evidence
Observed: As originally reported, annual revenue grew 25% and GAAP net income was $43 million.
Interpretation: Commercial results improved, while the annual shareholder series shows a lower 2017 endpoint. Later revenue-standard restatements must not replace the contemporary vintage silently.
Read the original source ↗sec filing · outcome evidence
Observed: AMD described its 7nm Ryzen and second-generation EPYC launches; 2019 revenue grew 4% and gross margin rose from 38% to 43%.
Interpretation: Improved mix, margins and product execution offer testable business explanations for a renewed investment wave, but do not isolate causality.
Underlying event / reporting date: 28 Dec 2019. Publicly available: 5 Feb 2020.
Later outcome evidence. This source must not be used as a signal available before the episode ended.
Read the original source ↗CHALLENGE THE STORY
TEST THE NEXT RESEMBLANCE
The annual shareholder rise and later margin improvement are documented; the specific recognition windows are not isolated.